Oncology refers to an area of ​​medical science that deals with tumors and tumors. The word onco means lump, mass or tumor while logia means study. A doctor who treats oncology is known as an oncologist. Usually, an oncologist takes care of care and treatment once a person is diagnosed with cancer. Say no to plagiarism. Get a tailor-made essay on "Why Violent Video Games Shouldn't Be Banned"? Get an Original Essay Cancer is an abnormal cell growth with the potential to spread or invade other parts of the body as well. Not all tumors are cancerous, and benign tumors do not extend to other parts of the body. Cancer also called malignant neoplasm or malignant tumor. Conference Series organizes numerous cancer conferences on different types of cancer such as breast cancer, leukemia, oral cancer, skin cancer, lung cancer, colon cancer, rectal cancer, prostate cancer, cervical cancer, melanoma and carcinoma. Symptoms may vary depending on the type. Cancer treatment may include chemotherapy, radiation therapy, and/or surgery. Now daily vaccines were also available for specific cancers. Many oncology and cancer conferences are organized into conference series. 3000+ global conference series events with 600+ conferences, 1200+ symposiums and 1200+ workshops on medical, pharmaceutical, engineering, science, technology and business in different parts of the world such as USA, Canada, Europe, UK, Middle East , United Arab Emirates and other Asia Pacific regions. Forums for young researchers, best poster awards, electronic posters, live streaming, B2B meetings, exhibitions and sponsorship opportunities are other significant features of these cancer meetings. Oncology conferences and cancer meetings provide an excellent opportunity for budding scientists and young researchers through its special initiatives such as Young Researchers Forum, Poster and E-poster Presentations and Live Streaming, B2B and Scientific Meetings. B2B meetings are a quick and easy way to meet potential cooperation partners. An estimated 12.7 million cancer cases and 7.6 million cancer deaths occurred worldwide in 2008, of which 56% of cases and 64% of deaths occurred in developing countries economic . Breast cancer, the most common cancer in women, has a high survival rate: 83% of patients survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal (colon and rectal) cancer, the most common malignant tumor if we group men and women together, has an average survival rate of 50-55% five years after diagnosis, which means that half of patients survive to this form of cancer. Prostate cancer, the most common cancer in men today, has an increasingly favorable prognosis, with an overall survival rate of 76%, higher in young adults. Ovarian cancer has a very varied prognosis depending on age: while 70% of the population between the ages of 15 and 44 survive this form of cancer, this applies to only 19% of people over the age of 74 . The global cancer/tumor market profile was valued at USD 13.30 billion in 2012. As of the end of 2013, the market is estimated at USD 14.99 billion and is poised to reach approximately USD 35 billion by 2018 , growing at a CAGR of 18.50% from 2013 to 2018. Global oncology spending hit $91 billion for 2013 and will grow at a rate of 5% annually,exceeding $100 billion in 2015. Major players in the cancer/tumor profiling market are Boreal Genomics Inc. (United States), Caris Life Sciences (United States), Genomic Health Inc. (United States), Illumina Inc. (United States), Life Technologies Corporation (United States), NeoGenomics Laboratories (United States), Oxford Gene Technology Ltd. (United States), Precision Therapeutics Inc. (United States), bioTheranostics (United States), Proteome Sciences PLC (United Kingdom), Agenda (Netherlands), Nanostring Technologies (United States), Rational Therapeutics (United States), Oncopath Laboratories (United States) and RiboMed Biotechnologies Inc. (NOI). The global oncology diagnostics market is expected to reach $13.1 billion in 2020 from an estimated $7.1 billion in 2015, growing at a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia and Rest of the World (RoW). The oncology diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. According to the global oncology drugs market, the market is expected to reach $111.9 billion by 2020. The expiration of the Patents of key cancer drugs such as Herceptin, Erbitux, Rituxan, and Avastin will spur growth of the cancer biosimilars market by 2020. Conference Series LLC has designed global platforms to interact and collaborate with renowned speakers, experts and industry professionals in its 3000+ global events with 600+ conferences, 1200+ symposiums and 1200+ workshops in diverse medical, pharmaceutical, engineering, scientific fields , technological and commercial. Oncology and cancer conferences hosted by Conference Series LLC focus on all types of common and rare cancers, as well as various modalities of diagnosis and treatment. Cancer is the name given to a collection of related diseases, a class of diseases characterized by out-of-control cell growth. In all types of cancer, some cells in the body begin to divide without stopping and spread to surrounding tissues. Cancer is a condition in which cells in a specific part of the body grow and reproduce uncontrollably. Cancer sometimes starts in one part of the body before spreading to other areas. This process is known as metastasis. Causes and presentation are the other main aspects of cancer research, there are few common causes while unique and organ-specific causes of cancer have also been found. Research is important and promising in the field of organ-specific research for a better understanding of organ-specific cancer and for the implementation of personalized treatment options. The study of cancer and tumors is known as oncology. The term oncology can literally be separated into two parts: “onco” means lump, mass, or tumor, while “-logy” means study. A doctor who specializes in treating people with cancer is called an oncologist. Typically, an oncologist manages care and treatment once a person is diagnosed with cancer. Scope and importance. Cancer is considered a major cause of morbidity and mortality worldwide. This is a complex health problem that requires a multidisciplinary approach. This approach is far-reaching and ranges from health promotion to prevention and screening, diagnosis, treatment, rehabilitation and palliative care, it is essential to remember that cancer is not one disease: there are more than 200, all different, unique diseases, which require different approaches to treatment. . Treatments that work for some cancers don't work for others, and sometimes these treatments simply stop working. Cancer research can range from the prevention of..